Psychotropic polypharmacy is common in Alzheimer's disease

October 1, 2018, University of Eastern Finland
PET scan of a human brain with Alzheimer's disease. Credit: public domain

Up to half of people with Alzheimer's disease (AD) use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

Psychotropic drug use was more common among persons with Alzheimer's disease already five years before the diagnosis, and the difference in persons without AD increased at the time of diagnosis. Four years after the diagnosis, psychotropic drug use was three times more common in persons with AD than in comparison persons.

Of , the use of antipsychotics was almost eight times more common among persons with Alzheimer's disease than among comparison persons. There were no differences in the use of benzodiazepines and related drugs. The use of at least two psychotropics concomitantly was three times more common among persons with Alzheimer's disease four years after the . The most common combination included an antidepressant together with either an antipsychotic or a benzodiazepine.

The use of first-line anti-dementia drugs, namely , was associated with a decreased risk of psychotropic polypharmacy, whereas memantine use was associated with an increased risk. The results were published in European Neuropsychopharmacology.

"Concomitant use of psychotropics is concerning, as previous studies have shown that there is a link between several adverse events and psychotropic drug use among older persons and persons with dementia," says Professor Sirpa Hartikainen from the University of Eastern Finland.

Guidelines of care in many countries recommend prescribing an acetylcholinesterase inhibitor to persons with Alzheimer's disease, if there is no contraindication for use.

This study was part of the nationwide register-based MEDALZ study conducted at the University of Eastern Finland. The study included all 70,718 persons diagnosed with Alzheimer's disease in Finland during 2005-2011. Researchers from Utrecht University also contributed to this study.

Explore further: More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

More information: Kim Orsel et al. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease, European Neuropsychopharmacology (2018). DOI: 10.1016/j.euroneuro.2018.04.005

Related Stories

More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

October 3, 2016
Psychotropic drug use is rather common among persons aged 90 years or more diagnosed with Alzheimer's disease, compared with those who were diagnosed at younger age, concludes a study conducted at the University of Eastern ...

Alzheimer's patients are more often hospitalized after initiating antibiotic use

September 18, 2018
People with Alzheimer's disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows. The risk of hospitalization was 40 per cent higher ...

Benzodiazepines associated with increased risk of Alzheimer's disease

August 13, 2018
The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer's disease, according to a recent study from the University of Eastern Finland. The risk increase was similar ...

Benzodiazepines increase mortality in persons with Alzheimer's disease

November 20, 2017
Benzodiazepine and related drug use is associated with a 40 percent increase in mortality among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The findings were published ...

Antidepressant use begins years before Alzheimer's diagnosis

March 4, 2016
Antidepressants are frequently prescribed to persons with Alzheimer's disease before the diagnosis, according to a recent study from the University of Eastern Finland. Among persons with Alzheimer's disease, the initiation ...

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

August 9, 2017
Antidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. Antidepressant ...

Recommended for you

Hypothesis underpinning dementia research 'flawed'

October 16, 2018
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Many cases of dementia may arise from non-inherited DNA 'spelling mistakes'

October 15, 2018
Only a small proportion of cases of dementia are thought to be inherited—the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, a team of scientists led by researchers ...

Scientists create new map of brain region linked to Alzheimer's disease

October 8, 2018
Curing some of the most vexing diseases first requires navigating the world's most complex structure—the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.

Previously unknown genetic aberrations found to be associated with Alzheimer's progression

October 8, 2018
In a large-scale analysis of RNA from postmortem human brain tissue, researchers at the Icahn School of Medicine at Mount Sinai and Columbia University have identified specific RNA splicing events associated with Alzheimer's ...

Periodontal disease bacteria may kick-start Alzheimer's

October 4, 2018
Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer's disease in humans, according to a new study from researchers at ...

AI could predict cognitive decline leading to Alzheimer's disease in the next five years

October 4, 2018
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.